Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Youshia

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Expert Opinion on Drug Delivery|December 5, 2015
Size-dependent nanoparticulate drug delivery in inflammatory bowel diseasesJohn Youshia, Alf Lamprecht
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|July 12, 2017
Artificial neural network based particle size prediction of polymeric nanoparticlesJohn Youshia, Mohamed Ehab Ali, Alf Lamprecht
Nanomedicine : Nanotechnology, Biology, and Medicine|June 21, 2020
Nanoparticles' properties modify cell type-dependent distribution in immune cellsJohn Youshia, Mohamed Ehab Ali, Valentin Stein, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|May 22, 2021
Gamma sterilization and in vivo evaluation of cationic nanostructured lipid carriers as potential ocular delivery systems for antiglaucoma drugsJohn Youshia, Amany O Kamel, Abdelhameed El Shamy, et al.
International Journal of Nanomedicine|June 9, 2012
Design of cationic nanostructured heterolipid matrices for ocular delivery of methazolamideJohn Youshia, Amany O Kamel, Abdelhameed El Shamy, et al.
Expert Opinion on Drug Delivery|June 26, 2023
Nose to brain delivery of naringin-loaded chitosan nanoparticles for potential use in oxaliplatin-induced chemobrain in rats: impact on oxidative stress, cGAS/STING and HMGB1/RAGE/TLR2/MYD88 inflammatory axesDiana M F Hanna, John Youshia, Sarah Farid Fahmy, et al.
Archiv Der Pharmazie|July 29, 2024
Nanocarriers for the treatment of glioblastoma multiforme: A succinct review of conventional and repositioned drugs in the last decadeMahitab Bayoumi, John Youshia, Mona G Arafa, et al.
Pharmaceutics|January 26, 2024
Gastroprotective Chitosan Nanoparticles Loaded with Oleuropein: An In Vivo Proof of ConceptHend Abd-Allah, John Youshia, Gehad A Abdel Jaleel, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|January 26, 2026
Re-purposed phenobarbital-loaded squarticles: A novel approach for the topical management of chemotherapy-induced alopecia"Salma A Fereig, John Youshia, Ghada M El-Zaafarany, et al.
Pharmaceuticals (Basel, Switzerland)|July 30, 2025
Chitosan Nanoparticles for Topical Drug Delivery in Chemotherapy-Induced Alopecia: A Comparative Study of Five Repurposed Pharmacological AgentsSalma A Fereig, John Youshia, Ghada M El-Zaafarany, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Expert Opinion on Drug Delivery|December 5, 2015
Size-dependent nanoparticulate drug delivery in inflammatory bowel diseasesJohn Youshia, Alf Lamprecht
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|July 12, 2017
Artificial neural network based particle size prediction of polymeric nanoparticlesJohn Youshia, Mohamed Ehab Ali, Alf Lamprecht
Nanomedicine : Nanotechnology, Biology, and Medicine|June 21, 2020
Nanoparticles' properties modify cell type-dependent distribution in immune cellsJohn Youshia, Mohamed Ehab Ali, Valentin Stein, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|May 22, 2021
Gamma sterilization and in vivo evaluation of cationic nanostructured lipid carriers as potential ocular delivery systems for antiglaucoma drugsJohn Youshia, Amany O Kamel, Abdelhameed El Shamy, et al.
International Journal of Nanomedicine|June 9, 2012
Design of cationic nanostructured heterolipid matrices for ocular delivery of methazolamideJohn Youshia, Amany O Kamel, Abdelhameed El Shamy, et al.
Expert Opinion on Drug Delivery|June 26, 2023
Nose to brain delivery of naringin-loaded chitosan nanoparticles for potential use in oxaliplatin-induced chemobrain in rats: impact on oxidative stress, cGAS/STING and HMGB1/RAGE/TLR2/MYD88 inflammatory axesDiana M F Hanna, John Youshia, Sarah Farid Fahmy, et al.
Archiv Der Pharmazie|July 29, 2024
Nanocarriers for the treatment of glioblastoma multiforme: A succinct review of conventional and repositioned drugs in the last decadeMahitab Bayoumi, John Youshia, Mona G Arafa, et al.
Pharmaceutics|January 26, 2024
Gastroprotective Chitosan Nanoparticles Loaded with Oleuropein: An In Vivo Proof of ConceptHend Abd-Allah, John Youshia, Gehad A Abdel Jaleel, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|January 26, 2026
Re-purposed phenobarbital-loaded squarticles: A novel approach for the topical management of chemotherapy-induced alopecia"Salma A Fereig, John Youshia, Ghada M El-Zaafarany, et al.
Pharmaceuticals (Basel, Switzerland)|July 30, 2025
Chitosan Nanoparticles for Topical Drug Delivery in Chemotherapy-Induced Alopecia: A Comparative Study of Five Repurposed Pharmacological AgentsSalma A Fereig, John Youshia, Ghada M El-Zaafarany, et al.
Pageof 2